AVIR FY 2020 Earnings — Atea Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AVIRAtea Pharmaceuticals, Inc.

$501M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$49M

Gross Profit

$11M21.8% margin

Operating Income

-$11M-22.7% margin

Net Income

-$11M-22.5% margin

EPS (Diluted)

$-0.13

Cash Flow

Operating Cash Flow

$297M

Free Cash Flow

$297M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$864M

Total Liabilities

$316M

Stockholders' Equity

$548M

Cash & Equivalents

$850M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$0	—
Gross Profit	$11M	-$17,000	+62511.8%
Operating Income	-$11M	-$15M	+24.5%
Net Income	-$11M	-$13M	+18.7%